Velarion Records
Free. Unsubscribe any time.

ImmunityBio, Inc. (IBRX)

ImmunityBio, Inc. filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 14 transactions and 937,410 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in ImmunityBio, Inc. 14

Adoption dates in ImmunityBio, Inc. 5

Results prints in ImmunityBio, Inc. 0

Trades before a print in ImmunityBio, Inc. 0

Interval to ImmunityBio, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates ImmunityBio, Inc. states

Filing text: “10b5-1 trading plan entered into by the Reporting Person on February 27, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

ImmunityBio, Inc.’s insider trading plan record — 10 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001326110.